Q91WU5
Gene name |
As3mt (Cyt19) |
Protein name |
Arsenite methyltransferase |
Names |
Methylarsonite methyltransferase, S-adenosyl-L-methionine:arsenic(III) methyltransferase |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:57344 |
EC number |
2.1.1.137: Methyltransferases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q91WU5
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q91WU5-F1 | Predicted | AlphaFoldDB |
20 variants for Q91WU5
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3389560471 | 8 | D>N | No | EVA | |
| rs3389523753 | 9 | E>K | No | EVA | |
| rs13463721 | 33 | C>Y | No | EVA | |
| rs3389511493 | 81 | G>E | No | EVA | |
| rs3389523812 | 85 | D>V | No | EVA | |
| rs13463720 | 106 | E>K | No | EVA | |
| rs3389537872 | 138 | E>* | No | EVA | |
| rs3389555906 | 185 | S>N | No | EVA | |
| rs3389555913 | 195 | E>D | No | EVA | |
| rs3389544765 | 213 | Y>N | No | EVA | |
| rs254223141 | 219 | I>M | No | EVA | |
| rs237996267 | 237 | I>V | No | EVA | |
| rs232506357 | 247 | V>F | No | EVA | |
| rs3389523794 | 258 | F>C | No | EVA | |
| rs3389537836 | 292 | N>Y | No | EVA | |
| rs50841425 | 299 | E>K | No | EVA | |
| rs3389511438 | 319 | D>E | No | EVA | |
| rs251162425 | 328 | S>L | No | EVA | |
| rs3389544793 | 334 | G>S | No | EVA | |
| rs46787138 | 335 | R>H | No | EVA |
No associated diseases with Q91WU5
No regional properties for Q91WU5
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q91WU5 | |||
Functions
| Description | ||
|---|---|---|
| EC Number | 2.1.1.137 | Methyltransferases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| arsenite methyltransferase activity | Catalysis of the reaction: S-adenosyl-L-methionine + arsenite = S-adenosyl-L-homocysteine + methylarsonate. |
| methylarsonite methyltransferase activity | Catalysis of the reaction: S-adenosyl-L-methionine + methylarsonite = S-adenosyl-L-homocysteine + dimethylarsinate. |
| methyltransferase activity | Catalysis of the transfer of a methyl group to an acceptor molecule. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| arsonoacetate metabolic process | The chemical reactions and pathways involving arsonoacetate, a synthetic, organic compound containing a single arsenic atom. Arsonoacetate and other arsenic containing compounds are used in agricultural applications as animal feed additives, cotton defoliants and post-emergence grass herbicides. |
| methylation | The process in which a methyl group is covalently attached to a molecule. |
| response to arsenic-containing substance | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides. |
| toxin metabolic process | The chemical reactions and pathways involving a toxin, a poisonous compound (typically a protein) that is produced by cells or organisms and that can cause disease when introduced into the body or tissues of an organism. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAASRDADEI | HKDVQNYYGN | VLKTSADLQT | NACVTRAKPV | PSYIRESLQN | VHEDVSSRYY |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GCGLTVPERL | ENCRILDLGS | GSGRDCYVLS | QLVGEKGHVT | GIDMTEVQVE | VAKTYLEHHM |
| 130 | 140 | 150 | 160 | 170 | 180 |
| EKFGFQAPNV | TFLHGRIEKL | AEAGIQSESY | DIVISNCVIN | LVPDKQQVLQ | EVYRVLKHGG |
| 190 | 200 | 210 | 220 | 230 | 240 |
| ELYFSDVYAS | LEVPEDIKSH | KVLWGECLGG | ALYWKDLAII | AQKIGFCPPR | LVTADIITVE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| NKELEGVLGD | CRFVSATFRL | FKLPKTEPAE | RCRVVYNGGI | KGHEKELIFD | ANFTFKEGEA |
| 310 | 320 | 330 | 340 | 350 | 360 |
| VAVDEETAAV | LKNSRFAPDF | LFTPVDASLP | APQGRSELET | KVLIRDPFKL | AEDSDKMKPR |
| 370 | |||||
| HAPEGTGGCC | GKRKNC |